Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors

doi:10.3748/wjg.v17.i2.219

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3938)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

392

HTML

3066

Figures (1-4)

262

Tables (1-3)

218

Sum=3938

Jan 14, 2011 (publication date) through Jan 6, 2025

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 14, 2011; 17(2): 219-225
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.219

Full Size Figure Download Figure

Figure 4 Kaplan-Meier survival analysis for endoglin tumor levels (A), vascular endothelial growth factor tumor levels (B), endoglin microvessel density (C) and CD31 microvessel density (D). Patients were divided into two groups based on mean tumor levels (A and B) or mean microvessel density (MVD) scores (C and D). None of the parameters showed a significant correlation with patient survival. VEGF: Vascular endothelial growth factor.

Citation: Kuiper P, Hawinkels LJ, Jonge-Muller ES, Biemond I, Lamers CB, Verspaget HW. Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2011; 17(2): 219-225
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/219.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i2.219